142 related articles for article (PubMed ID: 12652450)
21. [Causes and mechanisms of systemic vasculitides].
Mouthon L
Rev Prat; 2008 Mar; 58(5):487-91. PubMed ID: 18524104
[TBL] [Abstract][Full Text] [Related]
22. Do antineutrophil cytoplasmic autoantibodies cause Wegener's granulomatosis and other forms of necrotizing vasculitis?
Jennette JC; Ewert BH; Falk RJ
Rheum Dis Clin North Am; 1993 Feb; 19(1):1-14. PubMed ID: 8356246
[TBL] [Abstract][Full Text] [Related]
23. Granulomatous vasculitis.
Hammar SP
Semin Respir Infect; 1995 Jun; 10(2):107-20. PubMed ID: 7569400
[TBL] [Abstract][Full Text] [Related]
24. The antineutrophil cytoplasmic antibody-associated vasculitides.
Seo P; Stone JH
Am J Med; 2004 Jul; 117(1):39-50. PubMed ID: 15210387
[TBL] [Abstract][Full Text] [Related]
25. [Treatment of ANCA associated systemic necrotizing vasculitides].
Guillevin L
Bull Acad Natl Med; 2008; 192(6):1175-87; discussion 1188. PubMed ID: 19235481
[TBL] [Abstract][Full Text] [Related]
26. Wegener's granulomatosis triggered by infection?
Boudewyns A; Verbelen J; Koekelkoren E; Van Offel J; Van de Heyning P
Acta Otorhinolaryngol Belg; 2001; 55(1):57-63. PubMed ID: 11256193
[TBL] [Abstract][Full Text] [Related]
27. Value of a new automated fluorescence immunoassay (EliA) for PR3 and MPO-ANCA in monitoring disease activity in ANCA-associated systemic vasculitis.
Sinico RA; Radice A; Corace C; DI Toma L; Sabadini E
Ann N Y Acad Sci; 2005 Jun; 1050():185-92. PubMed ID: 16014533
[TBL] [Abstract][Full Text] [Related]
28. Chronic crusting, nasal carriage of Staphylococcus aureus and relapse rate in pulmonary Wegener's granulomatosis.
Zycinska K; Wardyn KA; Zielonka TM; Demkow U; Traburzynski MS
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():825-31. PubMed ID: 19218710
[TBL] [Abstract][Full Text] [Related]
29. Functionally relevant variations of the interleukin-10 gene associated with antineutrophil cytoplasmic antibody-negative Churg-Strauss syndrome, but not with Wegener's granulomatosis.
Wieczorek S; Hellmich B; Arning L; Moosig F; Lamprecht P; Gross WL; Epplen JT
Arthritis Rheum; 2008 Jun; 58(6):1839-48. PubMed ID: 18512809
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome.
Sinico RA; Di Toma L; Maggiore U; Bottero P; Radice A; Tosoni C; Grasselli C; Pavone L; Gregorini G; Monti S; Frassi M; Vecchio F; Corace C; Venegoni E; Buzio C
Arthritis Rheum; 2005 Sep; 52(9):2926-35. PubMed ID: 16142760
[TBL] [Abstract][Full Text] [Related]
31. Pathogenesis of Wegener's granulomatosis: current concepts.
Sarraf P; Sneller MC
Expert Rev Mol Med; 2005 May; 7(8):1-19. PubMed ID: 15890083
[TBL] [Abstract][Full Text] [Related]
32. Current understanding of the pathogenesis of granulomatosis with polyangiitis (Wegener's).
Csernok E; Gross WL
Expert Rev Clin Immunol; 2013 Jul; 9(7):641-8. PubMed ID: 23899234
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of antineutrophil cytoplasmic antibodies in patients with various pulmonary diseases or multiorgan dysfunction.
Vassilopoulos D; Niles JL; Villa-Forte A; Arroliga AC; Sullivan EJ; Merkel PA; Hoffman GS
Arthritis Rheum; 2003 Apr; 49(2):151-5. PubMed ID: 12687504
[TBL] [Abstract][Full Text] [Related]
34. Cutaneous manifestations of Wegener's granulomatosis: a clinicopathologic study of 17 patients and correlation to antineutrophil cytoplasmic antibody status.
Comfere NI; Macaron NC; Gibson LE
J Cutan Pathol; 2007 Oct; 34(10):739-47. PubMed ID: 17880578
[TBL] [Abstract][Full Text] [Related]
35. Wegener's granulomatosis--autoimmunity to neutrophil proteinase 3.
Watorek E; Boratyńska M; Klinger M
Arch Immunol Ther Exp (Warsz); 2003; 51(3):157-67. PubMed ID: 12894870
[TBL] [Abstract][Full Text] [Related]
36. Antineutrophil cytoplasmic antibodies (ANCA).
Radice A; Sinico RA
Autoimmunity; 2005 Feb; 38(1):93-103. PubMed ID: 15804710
[TBL] [Abstract][Full Text] [Related]
37. Variations in performance characteristics of commercial enzyme immunoassay kits for detection of antineutrophil cytoplasmic antibodies: what is the optimal cut off?
Holle JU; Hellmich B; Backes M; Gross WL; Csernok E
Ann Rheum Dis; 2005 Dec; 64(12):1773-9. PubMed ID: 15843447
[TBL] [Abstract][Full Text] [Related]
38. What do antineutrophil cytoplasmic antibodies (ANCA) tell us?
Savige J; Pollock W; Trevisin M
Best Pract Res Clin Rheumatol; 2005 Apr; 19(2):263-76. PubMed ID: 15857795
[TBL] [Abstract][Full Text] [Related]
39. [Treatment of patients with Wegener's granulomatosis or ANCA-associated vasculitis].
Tervaert JW; Stegeman CA
Ned Tijdschr Geneeskd; 2003 Nov; 147(46):2265-7. PubMed ID: 14655291
[TBL] [Abstract][Full Text] [Related]
40. Predictive value of antineutrophil cytoplasmic antibodies in small-vessel vasculitis.
Lurati-Ruiz F; Spertini F
J Rheumatol; 2005 Nov; 32(11):2167-72. PubMed ID: 16265696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
